Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Carter

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Organic Letters|November 3, 2023
Rhodium(II)-Catalyzed Hinsberg Dearomatization Using TrimethylsilyldiazomethaneJason R Combs, David S Carter, Fengyi Gu, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depressionDavid S Carter, Hai-Ying Cai, Eun Kyung Lee, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2009
Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitorsMatthew C Lucas, David S Carter, Hai-Ying Cai, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosisAaron Korkegian, Theresa O'Malley, Yi Xia, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of painDavid S Carter, Muzaffar Alam, Haiying Cai, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of painAlam Jahangir, Muzaffar Alam, David S Carter, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistChristine E Brotherton-Pleiss, Michael P Dillon, Anthony P D W Ford, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2010
Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and painMatthew C Lucas, Robert J Weikert, David S Carter, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked AnalogsDavid S Carter, Robert T Jacobs, Yvonne R Freund, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Organic Letters|November 3, 2023
Rhodium(II)-Catalyzed Hinsberg Dearomatization Using TrimethylsilyldiazomethaneJason R Combs, David S Carter, Fengyi Gu, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depressionDavid S Carter, Hai-Ying Cai, Eun Kyung Lee, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2009
Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitorsMatthew C Lucas, David S Carter, Hai-Ying Cai, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosisAaron Korkegian, Theresa O'Malley, Yi Xia, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of painDavid S Carter, Muzaffar Alam, Haiying Cai, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of painAlam Jahangir, Muzaffar Alam, David S Carter, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistChristine E Brotherton-Pleiss, Michael P Dillon, Anthony P D W Ford, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2010
Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and painMatthew C Lucas, Robert J Weikert, David S Carter, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked AnalogsDavid S Carter, Robert T Jacobs, Yvonne R Freund, et al.
Pageof 2